摘要
目的探讨苯那普利对糖尿病大鼠肾皮质TGFβ1及其受体表达的影响。方法大鼠随机分单侧肾切除组(C组);糖尿病组(D组)及糖尿病苯那普利治疗组(10mg·kg-1·d-1,灌胃,DB组),观察4wk后各组血糖、血胰岛素、血肌酐水平及体重、肾重和肾组织蛋白含量的变化,采用荧光分光光度法测定血浆及肾皮质、髓质ACE活性。应用Northern杂交检测各组肾皮质TGFβ1,1α(IV)前胶原及FNmRNA表达;Western杂交检测各组肾皮质TGFβ1及细胞膜TβRⅠ蛋白表达。结果苯那普利治疗4wk后能够明显缓解糖尿病大鼠高血糖、低胰岛素血症、血肌酐水平上升及体重下降、肾脏肥大。Northern杂交表明糖尿病大鼠肾皮质TGFβ1、1α(IV)前胶原及FNmRNA表达分别3.94、4.25及1.50倍,Western杂交表明肾皮质TGFβ1及细胞膜TβRⅠ蛋白表达分别上调3.10、1.00倍,苯那普利治疗4wk后对它们均有明显抑制作用。另外,尽管糖尿病大鼠血浆ACE活性明显下降,肾皮质ACE活性却明显增加,苯那普利治疗后对血浆及肾皮质ACE活性抑制分别达92.00%和88.70%。结论苯那普利可抑制高血糖状态下肾皮质TG?
AIM To investigate the effect of benazepril on the expressions of TGFβ 1 and its receptor (TβR) in diabetic rat kidney cortex. METHODS The rats were randomly divided into following groups: uninephrectomized (group C), streptozotocin diabetic rats (group D) and diabetic rats treated with benazepril (10 mg·kg -1 ·d -1 , by gavage, group DB). Blood glucose, serum insulin, serum creatinine lever and body weight, kidney weight as well as renal protein protein content were observed after 4 weeks of treatment. ACE activities were measured by spectrofluorimetry in plasma, renal cortex and medulla. mRNA expressions of TGFβ 1, 1α(IV) precollagen and FN were determined by Northern blot; protein expressions of TGFβ 1 and TβRⅠ was measured by Western blot in renal cortex. RESULTS After 4 weeks of treatment, benazepril could significantly ameliorate hyperglycemia, decreased serum insulin, elevated serum creatinine and body weight loss, kidney hypertrophy. Northern blot showed the expressions of TGFβ 1, 1α(IV) precollagen, FN mRNA were increased by 3 94, 4 25 and 1 50 folds, respectively; Western blot showed the expressions of TGFβ 1 amd TβRⅠ were elevated by 3 10 and 1 10 folds. However, benazepril could significantly suppress their expressions. In addition, there was an increase in renal cortex ACE activities despite a decrease in plasma ACE activities. Administration of benazepril could reduce ACE activities in plasma and renal cortex by approximately 92 00%, 88 77%, respectively. CONCLUSION Benazepril could significantly suppress the expressions of TGFβ 1 and its receptor, These might be its main mechanism of nephroprotection in diabetic model.
出处
《中国药理学通报》
CAS
CSCD
北大核心
1999年第1期38-42,共5页
Chinese Pharmacological Bulletin
基金
美国中华医学基金会
国家自然科学基金
关键词
苯那普利
糖尿病
肾脏肥大
TGFΒ1
benazepril
diabetes
kidney hypertrophy
transforming growth factor β 1
transforming growth factor β receptor